401 related articles for article (PubMed ID: 25751647)
1. Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma.
Lendvai N; Cohen AD; Cho HJ
Bone Marrow Transplant; 2015 Jun; 50(6):770-80. PubMed ID: 25751647
[TBL] [Abstract][Full Text] [Related]
2. Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival.
Htut M; D'Souza A; Krishnan A; Bruno B; Zhang MJ; Fei M; Diaz MA; Copelan E; Ganguly S; Hamadani M; Kharfan-Dabaja M; Lazarus H; Lee C; Meehan K; Nishihori T; Saad A; Seo S; Ramanathan M; Usmani SZ; Gasparetto C; Mark TM; Nieto Y; Hari P
Biol Blood Marrow Transplant; 2018 Mar; 24(3):478-485. PubMed ID: 29079457
[TBL] [Abstract][Full Text] [Related]
3. Cellular immunotherapy as a therapeutic approach in multiple myeloma.
Liegel J; Avigan D; Rosenblatt J
Expert Rev Hematol; 2018 Jul; 11(7):525-536. PubMed ID: 29856648
[TBL] [Abstract][Full Text] [Related]
4. Cellular immunotherapy for multiple myeloma.
Rosenblatt J; Avigan D
Best Pract Res Clin Haematol; 2008 Sep; 21(3):559-77. PubMed ID: 18790455
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs.
Festuccia M; Martino M; Ferrando F; Messina G; Moscato T; Fedele R; Boccadoro M; Giaccone L; Bruno B
Expert Opin Biol Ther; 2015 Jun; 15(6):857-72. PubMed ID: 25865214
[TBL] [Abstract][Full Text] [Related]
6. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
Chung C
Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
[TBL] [Abstract][Full Text] [Related]
7. Autologous Lymphocyte Infusion Supports Tumor Antigen Vaccine-Induced Immunity in Autologous Stem Cell Transplant for Multiple Myeloma.
Cohen AD; Lendvai N; Nataraj S; Imai N; Jungbluth AA; Tsakos I; Rahman A; Mei AH; Singh H; Zarychta K; Kim-Schulze S; Park A; Venhaus R; Alpaugh K; Gnjatic S; Cho HJ
Cancer Immunol Res; 2019 Apr; 7(4):658-669. PubMed ID: 30745365
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work.
Bashir Q; Qazilbash MH
Curr Hematol Malig Rep; 2017 Apr; 12(2):126-135. PubMed ID: 28285435
[TBL] [Abstract][Full Text] [Related]
9. Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.
Danylesko I; Beider K; Shimoni A; Nagler A
Clin Dev Immunol; 2012; 2012():753407. PubMed ID: 22649466
[TBL] [Abstract][Full Text] [Related]
10. Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
Minnie SA; Hill GR
Front Immunol; 2021; 12():651288. PubMed ID: 33777050
[TBL] [Abstract][Full Text] [Related]
11. Advances in immunotherapy in multiple myeloma.
Boussi L; Niesvizky R
Curr Opin Oncol; 2017 Nov; 29(6):460-466. PubMed ID: 28877078
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma.
Podar K; Jager D
Curr Cancer Drug Targets; 2017; 17(9):782-805. PubMed ID: 28201977
[TBL] [Abstract][Full Text] [Related]
13. Immune therapy in multiple myeloma.
Luptakova K; Avigan D
Clin Adv Hematol Oncol; 2015 Nov; 13(11):767-75. PubMed ID: 27058703
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care.
Koehne G; Giralt S
Curr Opin Oncol; 2012 Nov; 24(6):720-6. PubMed ID: 22960558
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies.
Karp Leaf R; Cho HJ; Avigan D
Curr Hematol Malig Rep; 2015 Dec; 10(4):395-404. PubMed ID: 26338470
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy strategies in multiple myeloma.
Bae J; Munshi NC; Anderson KC
Hematol Oncol Clin North Am; 2014 Oct; 28(5):927-43. PubMed ID: 25212890
[TBL] [Abstract][Full Text] [Related]
17. Cellular and vaccine immunotherapy for multiple myeloma.
Garfall AL; Stadtmauer EA
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):521-527. PubMed ID: 27913524
[TBL] [Abstract][Full Text] [Related]
18. Drug-mediated and cellular immunotherapy in multiple myeloma.
Ritchie DS; Quach H; Fielding K; Neeson P
Immunotherapy; 2010 Mar; 2(2):243-55. PubMed ID: 20635931
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy strategies for multiple myeloma: the present and the future.
Locke FL; Nishihori T; Alsina M; Kharfan-Dabaja MA
Immunotherapy; 2013 Sep; 5(9):1005-20. PubMed ID: 23998734
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation.
Binsfeld M; Beguin Y; Belle L; Otjacques E; Hannon M; Briquet A; Heusschen R; Drion P; Zilberberg J; Bogen B; Baron F; Caers J
PLoS One; 2014; 9(11):e113764. PubMed ID: 25415267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]